[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371251-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371251-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinical-applications-of-artificial-intelligence-ai-in-human-cancer-is-it-time-to-update-the-diagnostic-and-predictive-models-in-managing-hepatocellular-carcinoma-hcc","Clinical Applications of Artificial Intelligence (AI) in Human Cancer - Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?","","Recent advances increasingly support Artificial intelligence (AI) as a transformative tool for managing hepatocellular carcinoma (HCC), the most common primary liver cancer. Rising worldwide HCC incidence is linked to expanding metabolic dysfunction-associated steatotic liver disease (MASLD), which drives chronic liver damage and early-stage occurrence. Despite progress, outcomes for advanced HCC remain poor, requiring further personalized strategies. Machine learning and neural networks can detect clinically relevant patterns and biomarkers in large datasets and routinely acquired ultrasound, enabling earlier diagnosis and stronger predictive performance, while improving metabolomics–radiomics-based models and personalized treatment selection.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-applications-of-artificial-intelligence-ai-in-human-cancer-is-it-time-to-update-the-diagnostic-and-predictive-models-in-managing-hepatocellular-carcinoma-hcc/371251/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-applications-of-artificial-intelligence-ai-in-human-cancer-is-it-time-to-update-the-diagnostic-and-predictive-models-in-managing-hepatocellular-carcinoma-hcc/371251.png","ImageObject",300,407,{"name":42,"@type":43},"Hazel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is updating diagnostic and predictive models for HCC important?","Question",{"text":63,"@type":64},"HCC incidence is increasing worldwide, and although management has progressed, prognosis for advanced-stage patients remains poor. This creates a need for more accurate, personalized diagnostic and predictive approaches.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does MASLD play in HCC risk?",{"text":68,"@type":64},"MASLD is increasingly common and is a leading cause of chronic hepatic damage, including steatosis and fibrosis, and it can lead to HCC even in early disease stages.",{"name":70,"@type":61,"acceptedAnswer":71},"How can AI improve HCC diagnosis and prediction in clinical practice?",{"text":72,"@type":64},"AI can analyze large volumes of clinical data and medical images, including routine ultrasound, to improve diagnostic accuracy and predictive model performance. It also supports tailored treatment decisions within multidisciplinary care.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371251,1790294568,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Review  \nClinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?  \nMario Romeo 1, Marcello Dallio 1, *, Carmine Napolitano 1, Claudio Basile 1, Fiammetta Di Nardo 1, Paolo Vaia 1, Patrizia Iodice 2 and Alessandro Federico 1  \nAcademic Editor: Daniele Giansanti  \nReceived: 23 December 2024  \nRevised: 20 January 2025  \nAccepted: 21 January 2025  \nPublished: 22 January 2025  \nCitation: Romeo, M.; Dallio, M.; Napolitano, C.; Basile, C.; Di Nardo, F.; Vaia, P.; Iodice, P.; Federico, A. Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? Diagnostics 2025, 15, 252. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)diagnostics15030252  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Hepatogastroenterology Division, Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80138 Naples, Italy; [mario.romeo@unicampania.it](mario.romeo@unicampania.it) (M.R.);  \ncarmine.napolitano1@studenti.unicampania.it (C.N.); [claudio.basile@studenti.unicampania.it](claudio.basile@studenti.unicampania.it) (C.B.);  \nfiammetta.dinardo@studenti.unicampania.it (F.D.N.); paolo.vaia@studenti.unicampania.it (P.V.);  \n[alessandro.federico@unicampania.it](alessandro.federico@unicampania.it) (A.F.)  \n2 Oncology Division, Monaldi Hospital, 80131 Naples, Italy; patrizia.iodice@ospedalideicolli.it  \n* [Correspondence: marcello.dallio@unicampania.it](Correspondence: marcello.dallio@unicampania.it); Tel.: +39-0815664311  \nAbstract: In recent years, novel findings have progressively and promisingly supported the potential role of Artificial intelligence (AI) in transforming the management of various neoplasms, including hepatocellular carcinoma (HCC) . HCC represents the most common primary liver cancer. Alarmingly, the HCC incidence is dramatically increasing worldwide due to the simultaneous “pandemic” spreading of metabolic dysfunction-associated steatotic liver disease (MASLD) . MASLD currently constitutes the leading cause of chronic hepatic damage (steatosis and steatohepatitis), fibrosis, and liver cirrhosis, configuring a scenario where an HCC onset has been reported even in the early disease stage. On the other hand, HCC represents a serious plague, significantly burdening the outcomes of chronic hepatitis B (HBV) and hepatitis C (HCV) virus-infected patients. Despite the recent progress in the management of this cancer, the overall prognosis for advanced-stage HCC patients continues to be poor, suggesting the absolute need to develop personalized healthcare strategies further. In this “cold war”, machine learning techniques and neural networks are emerging as weapons, able to identify the patterns and biomarkers that would have normally escaped human observation. Using advanced algorithms, AI can analyze large volumes of clinical data and medical images (including routinely obtained ultrasound data) with an elevated accuracy, facilitating early diagnosis, improving the performance of predictive models, and supporting the multidisciplinary (oncologist, gastroenterologist, surgeon, radiologist) team in opting for the best “tailored” individual treatment. Additionally, AI can significantly contribute to enhancing the effectiveness of metabolomics–radiomicsbased models, promoting the identification of specific HCC-pathogenetic molecules as new targets for realizing novel therapeutic regimens. In the era of precision medicine, integrating AI into routine clinical practice appears as a promisin","cbCaifuiiT364u7a","https://ap.wps.com/l/cbCaifuiiT364u7a","pdf",780211,22,"English","# Abstract\n# Background","[{\"question\":\"Why is updating diagnostic and predictive models for HCC important?\",\"answer\":\"HCC incidence is increasing worldwide, and although management has progressed, prognosis for advanced-stage patients remains poor. This creates a need for more accurate, personalized diagnostic and predictive approaches.\"},{\"question\":\"What role does MASLD play in HCC risk?\",\"answer\":\"MASLD is increasingly common and is a leading cause of chronic hepatic damage, including steatosis and fibrosis, and it can lead to HCC even in early disease stages.\"},{\"question\":\"How can AI improve HCC diagnosis and prediction in clinical practice?\",\"answer\":\"AI can analyze large volumes of clinical data and medical images, including routine ultrasound, to improve diagnostic accuracy and predictive model performance. It also supports tailored treatment decisions within multidisciplinary care.\"}]","Clinical Applications of Artificial Intelligence (AI) in Human Cancer - Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)? | PDF",1790191622,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39a2f274e49c760d55e4afd14b554d96.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c86f3ea845bc8f1b5555651722e5b6c.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70069f983dd4eb5482681a91e31bae02.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e8b227b3d62f46203029b9d7b6bbdd6.webp",980,1385]